About Us

Focus on Healthcare & Biotechnology Investor Relations

Stern IR is the premier investor relations firm focusing on the entrepreneurial healthcare and biotechnology industries.

In order to provide effective IR counsel in this sector, we ensure that we have comprehensive knowledge of the technical, regulatory and financial aspects of the business. We closely monitor industry trends to provide a comprehensive and up-to-the-minute approach to investor relations counsel.

We keep up to date on the frequent changes in financial markets and the healthcare and biotechnology industries. In addition, our clients’ needs change also: Stern IR recognizes the importance of routinely re-evaluating each client's IR program to achieve the greatest return on its investment in investor relations.

Access: Key Relationships with the Healthcare and
Biotechnology Investment Community

As a result of our industry focus, we have cultivated valuable relationships within the investment community and know all of the major players and industry events. We facilitate introductions with crucial contacts on Wall Street and help our clients develop and improve existing relationships.

In the biotechnology sector, investor conferences and industry events are an important part of a successful IR program. We leverage our relationships in the industry to target the highest quality events for each client and to help obtain the most value from each event. Through a combination of meetings and roadshows, we familiarize the financial community with our clients and their unique prospects.


Focus on Best Investor Relations Practices

While each client has its own set of specific goals and tactics, we believe that high-quality companies should operate their investor relations programs according to current best industry practice.

We work with our clients to convey news and information to research analysts and investors regularly and consistently, with special attention to timing, positioning, accuracy and fair disclosure policies. In addition, we provide appropriate guidance to clients to ensure they maintain the respect and trust that is vital to a company's reputation on Wall Street.

The Team

Our exceptional team of investor relations professionals offers a proven track record of delivering results. Years of experience and superior client service allow us to provide sophisticated and critical direction, unique insights and a total perspective to meet clients' needs.

+ more - less

Lilian Stern has been a senior investor relations counselor in the biotechnology industry for over 20 years, representing more than 300 companies ranging from start-ups to large-cap public companies, in a broad range of development stages and therapeutic areas. As Principal of Stern IR, she works closely with all client teams, providing skilled and knowledgeable IR counsel. Lilian previously worked as a biotechnology sell-side analyst at Donaldson, Lufkin & Jenrette/Credit Suisse First Boston and was also Vice President of Biotechnology at AgriCapital Corporation. She holds an A.B. in Molecular Biology with distinction from Cornell University and a J.D. with honors from Harvard Law School.

Lilian is a member of National Investor Relations Institute (NIRI) as well as the New York Biotechnology Association (NYBA). Lilian established the Stern IR Foundation in 2008 to make contributions and otherwise support charities related to autism and other human health issues, as well as organizations that support cultural, educational and religious institutions. She sits on the board of Springboard Enterprises, the premier platform where entrepreneurs, investors, and industry experts meet to build great women-led businesses. Lilian is an omnivorous reader, enjoys crossword puzzles and is an avid Schubert fan.

+ more - less

Sarah McCabe is a Vice President at the firm and has been with Stern IR since 2004. She leads several public and private client accounts and has worked alongside many clients through their IPO process. She has executed comprehensive IR programs for her clients and has extensive experience with drug approvals and launches, clinical trial results, corporate re-positioning, M&A and other related events. Sarah's previous work experience includes PR and Event Planning. She holds a Bachelor of Arts in Psychology from the University of Pennsylvania. Sarah enjoys spending time with her boys, summers at the beach in East Hampton, visiting Flywheel classes and eating at Philly’s restaurants.

+ more - less

Jesse Baumgartner is an Associate at Stern IR and joined the firm in early 2012. He leads and assists client accounts in a variety of roles, including strategic messaging and communications, tactical activity planning and broader industry analysis. He has worked with clients across a number of therapeutic areas and helped develop private company IR programs leading to IPOs, as well as public company IR plans and communications around earnings announcements, partnerships and analyst days. Before Stern IR, he spent time as a journalist and also worked in politics – both on individual campaigns and for a communications firm in Seattle, Northwest Passage Consulting. Jesse holds a Bachelor of Arts in History and Journalism from the University of North Carolina at Chapel Hill. He also passed the Level I CFA exam in 2014 and is a candidate for Level II. In his free time, Jesse enjoys traveling around the East Coast, training for races with his Brooklyn track club and working his way through U.S. presidential biographies.

+ more - less

Will O’Connor is an Analyst at Stern IR. He works with both public and private clients, assisting with the execution of their IR programs by planning roadshows, conducting targeted investor outreach and drafting investor collateral. He holds a Bachelor of Arts in Government & Law from Lafayette College. Will enjoys traveling, reading the NY Times and spending time at the New Jersey shore.

+ more - less

Stephanie joined Stern IR in 2004 and is a Vice President at the firm. She has worked with companies in a variety of therapeutic areas and development stages. She has experience working with a number of private companies, establishing IR programs and laying the groundwork for successful venture financing rounds and IPOs, and guiding many of these companies as they establish effective public company practices post-IPO. She has also worked with a wide range of public companies, implementing major communications and IR initiatives including analyst days, data announcements and scientific presentations, regulatory updates and recommendations, new product launches and M&A transactions. Her previous work experience includes positions in brand marketing and educational publishing. She graduated from Cornell University with a Bachelor of Arts degree in English. Stephanie enjoys exploring NYC with her husband, son and spunky Labradoodle, being a foodie, cycling and travel.

+ more - less

Beth is a Senior Associate at Stern IR and joined the firm in early 2013. She works with both public and private biotech clients across all stages of development. Her healthcare background has helped her to manage clients through their IR initiatives including new product launch strategies, IPO planning, clinical trial data announcements and scientific presentations. Prior to joining Stern IR, Beth worked for over six years as a healthcare analyst at two independent research firms. She has a Master’s in Public Health from Columbia University and an undergraduate degree in both Chemistry and Spanish from the University of Rochester. Beth likes to spend as much time as possible in the East Village, Sonoma California and Saratoga Springs NY.

+ more - less

Hannah Deresiewicz is a Senior Analyst at Stern IR and joined the firm in mid-2013. She works with international public and private clients, developing and implementing comprehensive investor relations programs that encompass strategic messaging and presentation review, in-depth research projects and perception studies, and tactical coordination around conferences, R&D days and special events. Hannah has experience advising private companies on the execution of crossover deals, acquisitions and IPOs, and assisting public companies with the drafting of communications around earnings announcements and partnerships.  She graduated summa cum laude, Phi Beta Kappa from Columbia University with a Bachelor of Arts in political science and sociology. Hannah is a life-long New York Yankees fan, but will forever be a devoted Bostonian!

+ more - less

Caity Law is an Analyst at Stern IR. She works with public, private and pre-IPO clients, assisting with their IR programs by conducting investor outreach and targeting, as well as drafting press releases and earnings materials. Before Stern IR, Caity held positions in fashion PR and marketing. She holds a Bachelor of Arts in Political Science and Journalism/Media Studies from Rutgers University. Caity is currently working towards her Master’s in Public Relations and Corporate Communications at New York University, but in her free time, she enjoys traveling, discovering hidden speakeasies and finding reasons to wear neon yellow.

Stern IR Foundation

We are proud that our clients are making critical contributions to treating many diseases for which there are important unmet medical needs. In their honor and as part of our commitment to the industries we serve, Stern IR supports the following charities: